alloxan has been researched along with bpc 157 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anic, T; Aralica, G; Buljat, G; Coric, V; Grabarevic, Z; Hahn, V; Mikus, D; Mise, S; Petek, M; Prkacin, I; Rotkvic, I; Rucman, R; Sebecic, B; Seiwerth, S; Separovic, J; Sikiric, P; Stancic-Rokotov, D; Turkovic, B; Ziger, T; Zoricic, I | 1 |
| Cuzić, S; Dominis-Kramarić, M; Glojnarić, I; Ivetić, V; Parnham, MJ; Radosević, S; Seveljević-Jaran, D | 1 |
2 other study(ies) available for alloxan and bpc 157
| Article | Year |
|---|---|
Pentadecapeptide BPC 157 attenuates gastric lesions induced by alloxan in rats and mice.
Topics: Alloxan; Animals; Anti-Ulcer Agents; Gastric Mucosa; Male; Mice; Mice, Inbred Strains; Peptide Fragments; Proteins; Rats; Rats, Wistar; Stomach Ulcer | 1999 |
Accelerated healing of excisional skin wounds by PL 14736 in alloxan-hyperglycemic rats.
Topics: Alloxan; Animals; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Male; Peptide Fragments; Proteins; Rats; Rats, Wistar; Wound Healing | 2006 |